NCT05371860

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic

• Status: Withdrawn
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Armando Giuliano · Academic / Other
• Sex: Female
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the feasibility, based on recruitment rate over a 3-year period, of enrolling patients for the omission of post-operative breast radiation following breast conserving surgery and sentinel node biopsy or axillary lymph node dissection in women with HER2+ breast cancer who achieve pathologic complete response.

Conditions

• Breast Cancer
• HER2-positive Breast Cancer

Interventions

Type	Name	Description
OTHER	Omit breast radiation	Omit breast radiation for 3 years after surgery

Timeline

• Start date: 2023-07-01
• Primary completion: 2028-10-01
• Completion: 2028-10-01
• First posted: 2022-05-12
• Last updated: 2023-09-22

Locations

1 site across 1 country: United States